Europlasma [ALEUP] vs Aurea [AURE] Detailed Stock Comparison
Europlasma
Euronext
Loading...
Aurea
Euronext
Loading...
TLDR: Quick Comparison Summary
Based on 17 vital metrics comparison: Europlasma wins in 9 metrics, Aurea wins in 5 metrics, with 0 ties. Europlasma appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Europlasma | Aurea | Better |
|---|---|---|---|
| P/E Ratio (TTM) | -0.04 | 50.18 | Europlasma |
| Price-to-Book Ratio | N/A | 0.73 | N/A |
| Debt-to-Equity Ratio | -1.23 | 59.18 | Europlasma |
| PEG Ratio | N/A | 19.66 | N/A |
| EV/EBITDA | -0.81 | 6.89 | Europlasma |
| Profit Margin (TTM) | -35.71% | -0.77% | Aurea |
| Operating Margin (TTM) | -56.40% | -0.63% | Aurea |
| Return on Equity | 137.19% | -2.93% | Europlasma |
| Return on Assets (TTM) | -30.38% | 0.27% | Aurea |
| Free Cash Flow (TTM) | $-12.40M | $6.84M | Aurea |
| 1-Year Return | 0.00% | -16.76% | Europlasma |
| Price-to-Sales Ratio (TTM) | 0.05 | 0.24 | Europlasma |
| Enterprise Value | $11.22M | $69.05M | Aurea |
| EV/Revenue Ratio | 0.26 | 0.31 | Europlasma |
| Revenue per Share (TTM) | $211 | $24 | Europlasma |
| Earnings per Share (Diluted) | $-0.02 | $-0.22 | Europlasma |
| Beta (Stock Volatility) | 1.47 | N/A | N/A |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Europlasma vs Aurea Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Europlasma | 33.33% | 0.00% | 0.00% | 0.00% | -66.67% | -75.00% |
| Aurea | -0.70% | 1.43% | -2.08% | 1.07% | 12.75% | 4.43% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Europlasma | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Aurea | -16.76% | -15.27% | 10.98% | -3.58% | 9.69% | 9.69% |
Performance & Financial Health Analysis: Europlasma vs Aurea
| Metric | ALEUP | AURE |
|---|---|---|
| Market Information | ||
| Market Cap | €2.25M | €53.49M |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 173,696,919 | 1,869 |
| 90 Day Avg. Volume | 114,625,380 | 1,571 |
| Last Close | €0.00 | €5.66 |
| 52 Week Range | €0.00 - €0.21 | €4.78 - €7.30 |
| % from 52W High | -99.62% | -22.47% |
| All-Time High | €0.01 (Jun 10, 2025) | €13.40 (Mar 07, 2022) |
| % from All-Time High | N/A | -57.76% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 2.29% | -0.18% |
| Quarterly Earnings Growth | N/A | N/A |
| Financial Health | ||
| Profit Margin (TTM) | -0.36% | -0.01% |
| Operating Margin (TTM) | -0.56% | -0.01% |
| Return on Equity (TTM) | 1.37% | -0.03% |
| Debt to Equity (MRQ) | -1.23 | 59.18 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | €-0.20 | €7.82 |
| Cash per Share (MRQ) | €0.03 | €2.94 |
| Operating Cash Flow (TTM) | €-10,884,000 | €13.73M |
| Levered Free Cash Flow (TTM) | €-5,817,000 | €11.28M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Europlasma vs Aurea
| Metric | ALEUP | AURE |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | -0.04 | 50.18 |
| Forward P/E | N/A | 19.66 |
| PEG Ratio | N/A | 19.66 |
| Price to Sales (TTM) | 0.05 | 0.24 |
| Price to Book (MRQ) | N/A | 0.73 |
| Market Capitalization | ||
| Market Capitalization | €2.25M | €53.49M |
| Enterprise Value | €11.22M | €69.05M |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 0.26 | 0.31 |
| Enterprise to EBITDA | -0.81 | 6.89 |
| Risk & Other Metrics | ||
| Beta | 1.47 | N/A |
| Book Value per Share (MRQ) | €-0.20 | €7.82 |
Financial Statements Comparison: Europlasma vs Aurea
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | ALEUP | AURE |
|---|---|---|
| Revenue/Sales | N/A | N/A |
| Cost of Goods Sold | N/A | N/A |
| Gross Profit | N/A | N/A |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | N/A | N/A |
| EBITDA | N/A | N/A |
| Pre-Tax Income | N/A | N/A |
| Income Tax | N/A | N/A |
| Net Income (Profit) | N/A | N/A |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | ALEUP | AURE |
|---|---|---|
| Cash & Equivalents | €1.74M | €30.84M |
| Total Current Assets | €38.66M | €113.89M |
| Total Current Liabilities | €50.30M | €85.05M |
| Long-Term Debt | €10.18M | €36.18M |
| Total Shareholders Equity | €-11.15M | €73.88M |
| Retained Earnings | €-15.29M | €56.37M |
| Property, Plant & Equipment | €53.24M | €34.60M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | ALEUP | AURE |
|---|---|---|
| Operating Cash Flow | N/A | N/A |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | ALEUP | AURE |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 173,696,919 | 1,869 |
| Average Daily Volume (90 Day) | 114,625,380 | 1,571 |
| Shares Outstanding | 52.64M | 9.36M |
| Float Shares | N/A | 1.51M |
| % Held by Insiders | N/A | 0.74% |
| % Held by Institutions | N/A | 0.09% |
Dividend Analysis & Yield Comparison: Europlasma vs Aurea
| Metric | ALEUP | AURE |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |